Abstract
Modern diabetes care may benefit a significant proportion of adults living with diabetes; however, these benefits may not be consistently realized among the heterogeneous subpopulation of elderly patients over 65 years of age. There are three clinical constraints that have been proposed as important considerations for individualizing diabetes care among elderly patients. Life expectancy should be an important determinant of the intensity of glucose control because intensive control has been found to prevent complications only after extended periods of treatment. Therefore, patients with limited life expectancy may not benefit from intensive glucose control. The time and attention of health care providers should also be considered a constrained resource that can be optimally allocated to care for elderly diabetes patients. In the face of multiple chronic conditions and symptomatic complaints, patients and their providers should prioritize diabetes care within the context of a patients overall health care plan. The complexity of chronic medications or polypharmacy is the final clinical constraint. Polypharmacy may increase the probability of adverse drug events and represent a significant burden on quality of life. More direct clinical investigation of elderly diabetes patients will be needed if we are to truly improve the quality of life of this growing subpopulation.
Keywords: Diabetes, Geriatrics, Polypharmacy, Falls, Hypoglycemia
Current Diabetes Reviews
Title: Appropriate Application of Evidence to the Care of Elderly Patients with Diabetes
Volume: 3 Issue: 4
Author(s): Elbert S. Huang
Affiliation:
Keywords: Diabetes, Geriatrics, Polypharmacy, Falls, Hypoglycemia
Abstract: Modern diabetes care may benefit a significant proportion of adults living with diabetes; however, these benefits may not be consistently realized among the heterogeneous subpopulation of elderly patients over 65 years of age. There are three clinical constraints that have been proposed as important considerations for individualizing diabetes care among elderly patients. Life expectancy should be an important determinant of the intensity of glucose control because intensive control has been found to prevent complications only after extended periods of treatment. Therefore, patients with limited life expectancy may not benefit from intensive glucose control. The time and attention of health care providers should also be considered a constrained resource that can be optimally allocated to care for elderly diabetes patients. In the face of multiple chronic conditions and symptomatic complaints, patients and their providers should prioritize diabetes care within the context of a patients overall health care plan. The complexity of chronic medications or polypharmacy is the final clinical constraint. Polypharmacy may increase the probability of adverse drug events and represent a significant burden on quality of life. More direct clinical investigation of elderly diabetes patients will be needed if we are to truly improve the quality of life of this growing subpopulation.
Export Options
About this article
Cite this article as:
Huang S. Elbert, Appropriate Application of Evidence to the Care of Elderly Patients with Diabetes, Current Diabetes Reviews 2007; 3 (4) . https://dx.doi.org/10.2174/1573399810703040260
DOI https://dx.doi.org/10.2174/1573399810703040260 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hypogonadotrophic Hypogonadism in Type 2 Diabetes, Obesity and the Metabolic Syndrome
Current Molecular Medicine Enhancing Endothelial Progenitor Cell Function Through Selective Estrogen Receptor Modulation: A Potential Approach to Cardiovascular Risk Reduction
Cardiovascular & Hematological Agents in Medicinal Chemistry The Role of Mass Spectrometry in the “Omics” Era
Current Organic Chemistry Synthesis and Investigation of the Role of Benzopyran Dihydropyrimidinone Hybrids in Cell Proliferation, Migration and Tumor Growth
Anti-Cancer Agents in Medicinal Chemistry The Rabbit as an Experimental and Production Animal: From Genomics to Proteomics
Current Protein & Peptide Science The Synthetic and Biological Attributes of Pyrazole Derivatives: A Review
Mini-Reviews in Medicinal Chemistry Cardiovascular Disease Risk and Hormone Replacement Therapy (HRT): A Review Based on Randomised, Controlled Studies in Postmenopausal Women
Current Medicinal Chemistry Management of Obesity in Patients with Type 2 Diabetes Mellitus
Current Diabetes Reviews Influence of Lifestyle Measures on Hypertriglyceridaemia
Current Drug Targets Clinical Applications of Cardiovascular Magnetic Resonance
Current Pharmaceutical Design Precision Medicine and a Patient-Orientated Approach: Is this the Future for Tracking Cardiovascular Disorders?
Current Pharmaceutical Design Hematopoietic Growth Factors Support in the Elderly Cancer Patients Treated with Antiblastic Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Systems Medicine Approaches for the Definition of Complex Phenotypes in Chronic Diseases and Ageing. From Concept to Implementation and Policies
Current Pharmaceutical Design Colchicine in Coronary Artery Disease: An Old Acquaintance in New Attire?
Current Medicinal Chemistry Use of Chou’s 5-steps Rule to Study the Effect of Cereal Dietary Protein on Liver and Coronary Heart Disease Prevention
Current Nutrition & Food Science Prevention of Macrovascular Disease in Type 2 Diabetic Patients: Blockade of the Renin-Angiotensin-Aldosterone System
Current Diabetes Reviews Recent Trends in the Design, Synthesis and Biological Exploration of β-Lactams
Current Medicinal Chemistry Angiotensin-Converting Enzyme 2 Roles in the Pathogenesis of COVID-19
Current Hypertension Reviews Exploring the Influence of Mutation on Transthyretin Aggregation in Heart Disease
Current Computer-Aided Drug Design In Vitro and In Vivo Assessment of Matrix Type Transdermal Therapeutic System of Labetalol Hydrochloride
Current Drug Delivery